| Source HCPCS Code |
|
Target NDC Code |
J2252
Inj., midazolam in 0.8 percent sodium chloride, IV, not therapeutically equivalent to J2250, 1 mg
|
⇄
|
00264-8002-32
MIDAZOLAM 100 MG/100 ML-0.8%NACL
|
| Detail Information |
| Relationship Start Date |
10/15/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BAG |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J2252
Inj., midazolam in 0.8 percent sodium chloride, IV, not therapeutically equivalent to J2250, 1 mg
|
⇄
|
00264-8005-31
MIDAZOLAM 50 MG/50 ML-0.8%NACL
|
| Detail Information |
| Relationship Start Date |
10/15/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BAG |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J2252
Inj., midazolam in 0.8 percent sodium chloride, IV, not therapeutically equivalent to J2250, 1 mg
|
⇄
|
51754-2131-01
MIDAZOLAM 100 MG/100 ML-0.8% NACL
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
10/02/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J2252
INJECTION, MIDAZOLAM IN 0.8% SODIUM CHLORIDE, INTRAVENOUS, NOT THERAPEUTICALLY EQUIVALENT TO J2250, 1 MG
|
⇄
|
51754-2131-04
MIDAZOLAM-SODIUM CHLORIDE (25X100ML;SDV,PF) 100 MG/100 ML-0.8%
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|